Evidence map›Paper›PMID 25961514›Full record

ReviewBioconjugate chemistry2015

Molecular probes for fluorescence lifetime imaging.

Pinaki Sarder, Dolonchampa Maji, Samuel Achilefu

Abstract readReview
In one paragraph

Review in Bioconjugate chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Label-free metabolic imaging ofFrontiers in cellular and infection microbiology · 2025
    Article
  6. Self-Reporting Therapeutic Protein Nanoparticles.ACS applied materials & interfaces · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Bioimaging with Upconversion Nanoparticles.Advanced photonics research · 2022
    Article
  12. Nanomaterials Used in Fluorescence Polarization Based Biosensors.International journal of molecular sciences · 2022
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pinaki Sarder†Departments of Radiology, ‡Biomedical Engineering, and §Biochemistry and Molecular Biophysics, Washington University School of Medicine, 4525 Scott Avenue, St. Louis, Missouri 63110, United States.
Dolonchampa Maji†Departments of Radiology, ‡Biomedical Engineering, and §Biochemistry and Molecular Biophysics, Washington University School of Medicine, 4525 Scott Avenue, St. Louis, Missouri 63110, United States.
Samuel Achilefu†Departments of Radiology, ‡Biomedical Engineering, and §Biochemistry and Molecular Biophysics, Washington University School of Medicine, 4525 Scott Avenue, St. Louis, Missouri 63110, United States.

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI AIMEE S JAMES · 2001 to 2026
$128.0M
WU-MDACC Inter-Institutional Molecular Imaging CenterP50CA094056 · NCI · WASHINGTON UNIVERSITY · PI PIWNICA-WORMS, DAVID · 2002 to 2016
$26.3M
21ST CENTURY IMAGING SCIENCES: GRADUATE STUDENT TRAININGT32EB014855 · NIBIB · WASHINGTON UNIVERSITY · PI JOSEPH P CULVER, JOSEPH A O'SULLIVAN · 2012 to 2026
$3.1M
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERYR01CA171651 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2013 to 2017
$2.8M
MOLECULAR PROBES AND METHODS FOR FLUORESCENCE LIFETIME TOMOGRAPHY AND MICROSCOPYR01EB008111 · NIBIB · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2009 to 2012
$1.9M
FLUORESCENCE LIFETIME IMAGING MICROSCOPY SYSTEMS10OD016237 · OD · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2014 to 2014
$267k
NCI NIH HHS P30 CA091842NCI NIH HHS P50 CA094056NCI NIH HHS P50CA094056NCI NIH HHS R01 CA171651NIBIB NIH HHS R01 EB008111NIBIB NIH HHS T32 EB014855NIH HHS S10 OD016237
6 · The paper itself

Abstract

Visualization of biological processes and pathologic conditions at the cellular and tissue levels largely relies on the use of fluorescence intensity signals from fluorophores or their bioconjugates. To overcome the concentration dependency of intensity measurements, evaluate subtle molecular interactions, and determine biochemical status of intracellular or extracellular microenvironments, fluorescence lifetime (FLT) imaging has emerged as a reliable imaging method complementary to intensity measurements. Driven by a wide variety of dyes exhibiting stable or environment-responsive FLTs, information multiplexing can be readily accomplished without the need for ratiometric spectral imaging. With knowledge of the fluorescent states of the molecules, it is entirely possible to predict the functional status of biomolecules or microevironment of cells. Whereas the use of FLT spectroscopy and microscopy in biological studies is now well-established, in vivo imaging of biological processes based on FLT imaging techniques is still evolving. This review summarizes recent advances in the application of the FLT of molecular probes for imaging cells and small animal models of human diseases. It also highlights some challenges that continue to limit the full realization of the potential of using FLT molecular probes to address diverse biological problems and outlines areas of potential high impact in the future.

Indexed as

AnimalsFluorescent DyesHumansMicroscopy, FluorescenceModels, MolecularMolecular ProbesOptical ImagingSpectrometry, FluorescenceFluorescent DyesMolecular Probes

Identifiers

PMID25961514
PMCPMC4482119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.